Whether you are a new T1D Family, a TrialNet participant, a healthcare provider, or a researcher — you'll find resources here.
We’re here to help you after a new T1D diagnosis. Get answers to frequently asked questions and learn about clinical studies testing ways to maintain insulin production.
While you wait for screening results, get answers to your questions, find out about next steps, and learn more about TrialNet’s Pathway to Prevention.
Your T1D families are important to you. Learn how easy it is to connect your patients with world-class T1D research.
University of California, San Francisco (UCSF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Stephen Gitelman, MD, the TrialNet team at UCSF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
University of Southern California
150 N. Robertson Blvd. Ste 210, Beverly Hills, CA 90211
Southern California Permanente Medical Group
3955 Bonita Road, Bonita, CA 91902
John Muir Physician Network Clinical Research Center
2700 Grant Street Suite 202, Concord, CA 94520
AMCR Institute, Inc.
625 West Citricado Pkwy, Suite 112, Escondido, CA 92026
East-West Medical Research Institute
1585 Kapiolani Blvd, #1500, Honolulu, HI 96814
The Whittier Institute for Diabetes
9898 Genesee Ave., 6th Floor, La Jolla, CA 92037
Palm Research Center, Inc
9280 W. Sunset Rd, Suite 306, Las Vegas, NV 89148
Childrens Hospital Los Angeles
4650 Sunset Blvd., Los Angeles, CA 90027
White Memorial Medical Center
1720 Cesar E. Chavez Ave., Los Angeles, CA 90033
Childrens Hospital and Research Center at Oakland
747 52nd St., Oakland, CA 94609
Phoenix Childrens Hospital
1919 E Thomas Road, Phoenix, AZ 85016
Center for Excellence in Diabetes and Endocrinology
3814 Auburn Blvd. Suite 72, Sacramento, CA 95821
Sutter Institute for Medical Research
2801 Capitol Ave, Suite 210, Sacramento, CA 95816
UC Davis, Pediatric Endocrinology
2516 Stockton Blvd., Sacramento, CA 95817
Pediatric Endocrinology of San Diego
7920 Frost St., Ste 304B, San Diego, CA 92123
3400 Lomita Blvd, Suite 209, Torrance, CA 90505
University of Arizona Pediatric Endocrinology
1501 N Campbell Ave, Tucson, AZ 85724
Diablo Clinical Research, Inc.
2255 Ygnacio Valley Road, Suite M, Walnut Creek, CA 94598
If you have a relative with T1D, you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for Pathway to Prevention screening to determine your risk of developing T1D.
TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression.
We tested the drug teplizumab to see if it could delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production.
We are testing the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (stage 3). HCQ is already used to reduce symptoms and progression of other autoimmune diseases, such as rheumatoid arthritis and lupus. This is the first study to see if it can prevent or delay T1D.
Once your study ends, we're still here for you. Participant monitoring and continued involvement helps us learn more about T1D.